Skip to main content
OpenTrials
Completed

NCT Number: NCT03178877

The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors

A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

IBS - Irritable Bowel Syndrome Anxiety Disorders Colonic Diseases Colonic Diseases, Functional Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Digestive System Diseases Gastrointestinal Diseases Genetic Diseases, Inborn Ichthyosis Ichthyosis Bullosa of Siemens Infant, Newborn, Diseases Intestinal Diseases Irritable Bowel Syndrome Keratosis Mental Disorders Skin Abnormalities Skin Diseases Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

15 year–30 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Cipto Mangunkusumo Hospital

Jakarta Pusat, DKI Jakarta, 10430, Indonesia

About this study

A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects. A bivariate analysis was done to know the relationship between IBS and its related factors using chi-square, unpaired t-test, and their alternatives. Multivariate analysis was done using logistic regression test

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age of participant >= 15 years
  • Volunteer to participate in study

Exclusion criteria

  • Red flag symptoms: febrile, vomiting, rectal bleeding, weight lost
  • Diagnosed as having Inflammatory bowel disease
  • Peptic ulcer drug consumption
  • History of gastrointestinal surgery

Treatment and study plan

No intervention

Other

Primary outcomes

  1. Anxiety and depression

    Time frame: 1 month

    Anxiety and Depression using Hospital Anxiety Depression Scale

Secondary outcomes

  1. Sleep Quality

    Time frame: 1 month

    Sleep quality using Pittsburg Sleep Quality Index

  2. Spiritual status

    Time frame: 1 month

    Spiritual status using Functional Assessment of Chronic Illness Therapy-Spiritual Wellbeing

  3. Academic Stress

    Time frame: 6 months

    Academic stress using Student-Life Stress Inventory

Sponsors and collaborators

Lead sponsor

Indonesia University

Other

Registry information

Acronym: IBS

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Jun 7, 2017
Registry last updated
Jun 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.